Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population

Journal of Rheumatology

Volumn 24, Issue 3, 1997, Pages 555-559

  Wolfe, Frederick ^a,b,f   Russell, I Jon ^c   Vipraio, Gilbert ^d   Ross, Kathryn ^c   Anderson, Janice ^e  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^b Wichita Arthr Res Clin Centers   (United States)

^c Department of Medicine ^*

^d UNIVERSITY OF TEXAS   (United States)

^e Arthritis Research Center   (United States)

^f Arthr Research and Clinical Centers   (United States)

Author keywords

depression; fibromyalgia; pain threshold; population study; serotonin; symptoms

Indexed keywords

SEROTONIN;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; FIBROMYALGIA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PAIN THRESHOLD; POPULATION RESEARCH; PRIORITY JOURNAL; SEROTONIN BLOOD LEVEL;

ANALYSIS OF VARIANCE; DEPRESSION; FEMALE; FIBROMYALGIA; HUMANS; KANSAS; MALE; PAIN THRESHOLD; PREVALENCE; SEROTONIN;

EID: 0030959929     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Houvenagel E: [Fibromyalgia: pathogenic concepts]. Rev Rhum Ed Fr 1993;60:223-8.
2. Vaeroy H, Helle R, Forre O, Kass E, Terenius L: Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: New features for diagnosis. Pain 1988;32:21-6.
3. Russell IJ, Vaeroy H, Javors M, Nyberg F: Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 1992;35:550-6.
4. Houvenagel E, Forzy G, Leloire O, et al: [Cerebrospinal fluid monoamines in primary fibromyalgia]. Rev Rheum Mal Osteoartic 1990;57:21-3.
5. 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome (letter); Russell IJ, Vipraio GA, Lopez Y: Reply. J Rheumatol 1993;20:1986-8.
6. Stratz T, Samborski W, Hrycaj P, et al: Serum serotonin concentrations in patients with generalized tendomyopathy (fibromyalgia) and rheumatoid arthritis. Med Klin 1993;88:458-62.
7. Russell IJ, Michalek JE, Vipraio GA, Fletcher EM, Javors MA, Bowden CA: Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome [see comments]. J Rheumatol 1992;19:104-9.
8. Risch SC, Nemeroff CB: Neurochemical alterations of serotonergic neuronal systems in depression. J Clin Psychiatry 1992;(suppl)53:3-7.
9. Grahame-Smith DG: Serotonin in affective disorders. Int Clin Psychopharmacol 1992;(suppl 4)6:5-13.
10. Wurtman JJ: Depression and weight gain: The serotonin connection. J Affect Disord 1993;29:183-92.
11. Benkert O, Wetzel H, Szegedi A: Serotonin dysfunction syndromes: A functional common denominator for classification of depression, anxiety, and obsessive-compulsive disorder. Int J Clin Psychopharmacol 1993;(suppl 1)8:3-14.
12. Linnoila VM, Virkkunen M: Aggression, suicidality, and serotonin. J Clin Psychiatry 1992;(suppl)53:46-51.
13. Glover V, Jarman J, Sandler M: Migraine and depression: Biological aspects. J Psychiatr Res 1993;27:223-31.
14. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L: The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28.
15. Wolfe F, Ross K, Anderson J, Russell IJ: Aspects of fibromyalgia in the general population: Sex, pain threshold, and fibromyalgia symptoms. J Rheumatol 1995;22:151-6.
16. Croft P, Rigby AS, Boswell R, Schollum J, Silman AJ: The prevalence of widespread pain in the general population. J Rheumatol 1993;20:710-3.
17. Croft P, Schollum J, Silman A: Population study of tender point counts and pain as evidence of fibromyalgia. BMJ 1994;309:696-9.
18. Wolfe F, Smythe HA, Yunus MB, et al: The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia: Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72.
19. Derogatis LR, Cleary PA: Confirmation of the dimensional structure of the SCL-90. J Clin Psychol 1977;33:981-9.
20. Meenan RF, Gertman PM, Mason JH: Measuring health status in arthritis: The Arthritis Impact Measurement Scales. Arthritis Rheum 1980;23:146-52.
21. Hawley DJ, Wolfe F: Depression is not more common in rheumatoid arthritis: A 10 year longitudinal study of 6,608 rheumatic disease patients. J Rheumatol 1993;20:2025-31.
22. Fischer AA: Pressure algometry over normal muscles. Standard values, validity and reproducibility of pressure threshold. Pain 1987;30:115-26.
23. Fischer AA: Pressure threshold meter: Its use for quantification of tender spots. Arch Phys Med Rehabil 1986;67:836-8.
24. Smythe HA, Buskila D, Gladman DD: Performance of scored palpation, a point count, and dolorimetry in assessing unsuspected nonarticular tenderness. J Rheumatol 1993;20:352-7.
25. Cathey MA, Wolfe F, Kleinheksel SM, Miller S, Pitetti KH: Functional ability and work status in patients with fibromyalgia. Arthritis Care Res 1988;1:85-98.
26. Fries JF, Spitz PW, Kraines RG: Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
27. Meenan RF: The AIMS approach to health status measurement: Conceptual background and measurement properties. J Rheumatol 1982;9:785-8.
28. Moldofsky H: Rheumatic pain modulation syndrome: The interrelationships between sleep, central nervous system serotonin, and pain. Adv Neurol 1982;33:51-7.
29. Moldofsky H, Warsh JJ: Plasma tryptophan and musculoskeletal pain in non-articular rheumatism ("fibrositis syndrome"). Pain 1978;5:65-71.
30. Harvey JA, Zemlan FP, Yunger LM: Behavioral correlates of serotonin depletion. Fed Proc 1975;34:1796-801.
31. Murphy RM, Zemlan FP: Differential effects of Substance-P on serotonin modulated spinal nociceptive reflexes. Psychopharmacology (Berlin) 1987;93:118-21.
32. Hertzman PA, Borda IA: The toxic oil syndrome and the eosinophilia-myalgia syndrome: Pursuing clinical parallels. J Rheumatol 1993;20:1707-10.